YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Lilly weight-loss drug approved by US, UK

Posted online

A weight-loss treatment from Eli Lilly has been given regulatory approval by the United States and United Kingdom.

Zepbound is expected to hit store shelves in the United States later this month.

Zepbound reportedly will be a rival to Novo Nordisk's Wegovy treatment.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences